Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator as a Biomarker in Breast Cancer Patients. (2023). Precision Medicine Communications, 3(1), 11-26. https://doi.org/10.55627/pmc.003.01.0300